Univariate and multivariate Cox regression analyses were performed on the 308 patients in the original cohort to determine the prognostic factors for HER2-positive BC patients who underwent TCbHP-based dual-target NAT followed by radical surgery (Table 5). Here, ERBB2 is linked to breast cancer.